ROCKVILLE, Md., June 8 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD - News) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that James S. Burns, President and Chief Executive Officer, will present a Company overview at the 5th Annual Needham & Company Biotechnology & Medical Technology Conference, to be held at the New York Palace Hotel, June 14-15, 2006. Mr. Burns' presentation is scheduled for Wednesday, June 14, 2006 at 11:30 a.m. (local time).
